查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1212646

末梢性动脉疾病(PAD)治疗药的全球市场

Peripheral Arterial Disease (PAD) Therapeutics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

末梢性动脉疾病(PAD)治疗药的全球市场2030年将达到70亿美元

在COVID-19后改变的商务环境中，2022年40亿美元的末梢性动脉疾病(PAD)治疗药的全球市场在2030年前将修正达到70亿美元的规模，在分析期间2022-2030年间将以7.1％的年复合成长率增长。本报告所分析的市场区隔之一的末梢支架将记录年复合成长率6.9％，到分析期间结束时将达到17亿美元。考虑疫情后的復苏，末梢血管成形术用气球市场区隔今后8年的年复合成长率将修正为6.4％。

美国市场估算为12亿美元，中国预测将以年复合成长率6.7％增长。

美国的末梢性动脉疾病(PAD)治疗药市场，2022年12亿美元。作为世界第2大经济大国的中国，在2022年到2030年间以年复合成长率6.7％推移在2030年前将修正达到12亿美元的市场规模。其他热门的地区市场有日本和加拿大，从2022年到2030各将以6.3％和5.9％的速度成长。在欧洲市场中，德国以年复合成长率5.5％成长。

调查对像企业范例

  • AstraZeneca Plc.
  • Bayer HealthCare Pharmaceuticals
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Proteon Therapeutics, Inc.
  • Sanofi S.A.
  • Symic Bio, Inc.
  • TheraVasc, Inc.

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP-6815

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Peripheral Arterial Disease (PAD) Therapeutics Market to Reach $7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$4 Billion in the year 2022, is projected to reach a revised size of US$7 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2022-2030. Peripheral Stents, one of the segments analyzed in the report, is projected to record a 6.9% CAGR and reach US$1.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Peripheral Angioplasty Balloons segment is readjusted to a revised 6.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 6.7% CAGR

The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 6.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 5.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Select Competitors (Total 32 Featured):

  • AstraZeneca Plc.
  • Bayer HealthCare Pharmaceuticals
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Proteon Therapeutics, Inc.
  • Sanofi S.A.
  • Symic Bio, Inc.
  • TheraVasc, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • PAD - A Prelude
    • Recent Market Activity
    • PAD Statistics
    • Critical Limb Ischemia - An Insight
    • High Costs - A Cause of Concern
    • Peripheral Arterial Disease (PAD) Therapeutics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
    • AstraZeneca Plc. (UK)
    • Bayer HealthCare Pharmaceuticals (Germany)
    • Bristol-Myers Squibb Company (US)
    • Merck & Co., Inc. (US)
    • Proteon Therapeutics, Inc. (US)
    • Sanofi S.A. (France)
    • Symic Bio, Inc. (US)
    • TheraVasc Inc. (US)
  • 3. MARKET TRENDS & DRIVERS
    • Aging - A Key Driver
    • High Diabetes Incidence Worldwide: Key Market Opportunity for PAD Therapeutics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Peripheral Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Peripheral Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Peripheral Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Inferior Vena Cava (IVC) Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Inferior Vena Cava (IVC) Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Inferior Vena Cava (IVC) Filters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Peripheral Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Peripheral Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Peripheral Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Peripheral Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Peripheral Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 24: World 18-Year Perspective for Peripheral Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 25: World Peripheral Arterial Disease (PAD) Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: World 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: USA 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: USA 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Canada 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: Canada 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • JAPAN
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Japan 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Japan 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • CHINA
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: China 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: China 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • EUROPE
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Europe 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: Europe 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: Europe 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
  • FRANCE
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: France 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: France 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • GERMANY
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: Germany 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: Germany 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: Italy 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: Italy 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: UK 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: UK 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: Rest of Europe 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: Rest of Europe 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: Asia-Pacific 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: Asia-Pacific 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Rest of World 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Percentage Breakdown of Value Sales for Peripheral Arterial Disease (PAD) Therapeutics for the Years 2012, 2023 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 103: Rest of World 18-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2012, 2023 & 2030

IV. COMPETITION